Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PBYI — Puma Biotechnology, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$304,984
+$201,000 QoQ
Shares Held
37,606
+131.1% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PBYI ranks #218 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PBYI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $304,984 37,606
2026-03-31 $103,984 16,273
2025-12-31 $287,271 48,281
2025-09-30 $172,739 32,531
2025-06-30 $96,129 28,026
2025-03-31 $69,406 23,448
2024-12-31 $69,933 22,929
2024-09-30 $42,847 16,803
2024-06-30 $53,627 16,450
2024-03-31 $44,074 8,316
2023-12-31 $1,346 311
2023-09-30 $775 295
2023-06-30 $1,020 289
2023-03-31 $840 272
2022-12-31 $1,129 267
2022-09-30 $616 260
2022-06-30 $721 253
2022-03-31 $404,625 140,495
2021-12-31 $655,934 215,768
2021-09-30 $1,801,743 257,025
2021-06-30 $2,060,633 224,470
2021-03-31 $2,120,475 218,156
2020-12-31 $832,494 81,140
2020-09-30 $1,028,048 101,888
2020-06-30 $954,385 91,504
2020-03-31 $768,613 91,068